Literature DB >> 20705698

Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome.

C P Hess1, H J Fullerton, D W Metry, B A Drolet, D H Siegel, K I Auguste, N Gupta, A N Haggstrom, C F Dowd, I J Frieden, A J Barkovich.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral and cervical arterial abnormalities are the most common non-cutaneous anomaly in PHACE syndrome, but the location and type of arterial lesions that occur have not been systematically assessed in a large cohort. Our aim was to characterize the phenotypic spectrum of arteriopathy, assess the frequency with which different arteries are involved, and evaluate spatial relationships between arteriopathy, brain structural lesions, and hemangiomas in PHACE syndrome.
MATERIALS AND METHODS: Intracranial MRA and/or CTA images from 70 children and accompanying brain MR images in 59 patients with arteriopathy and PHACE syndrome were reviewed to identify the type and location of arterial lesions and brain abnormalities. Five categories of arteriopathy were identified and used for classification: dysgenesis, narrowing, nonvisualization, primitive embryonic carotid-vertebrobasilar connections, and anomalous arterial course or origin. Univariate logistic regression analyses were performed to test for associations between arteriopathy location, hemangiomas, and brain abnormalities.
RESULTS: By study design, all patients had arterial abnormalities, and 57% had >1 form of arteriopathy. Dysgenesis was the most common abnormality (56%), followed by anomalous course and/or origin (47%), narrowing (39%), and nonvisualization (20%). Primitive embryonic carotid-vertebrobasilar connections were present in 20% of children. Hemangiomas were ipsilateral to arteriopathy in all but 1 case. The frontotemporal and/or mandibular facial segments were involved in 97% of cases, but no other specific associations between arteriopathy location and hemangioma sites were detected. All cases with posterior fossa anomalies had either ICA anomalies or persistent embryonic carotid-basilar connections.
CONCLUSIONS: The arteriopathy of PHACE syndrome commonly involves the ICA and its embryonic branches, ipsilateral to the cutaneous hemangioma, with dysgenesis and abnormal arterial course the most commonly noted abnormalities. Brain abnormalities are also typically ipsilateral.

Entities:  

Mesh:

Year:  2010        PMID: 20705698      PMCID: PMC5967888          DOI: 10.3174/ajnr.A2206

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Risk for PHACE syndrome in infants with large facial hemangiomas.

Authors:  Anita N Haggstrom; Maria C Garzon; Eulalia Baselga; Sarah L Chamlin; Ilona J Frieden; Kristen Holland; Sheilagh Maguiness; Anthony J Mancini; Catherine McCuaig; Denise W Metry; Kimberly Morel; Julie Powell; Susan M Perkins; Dawn Siegel; Beth A Drolet
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

2.  A report of two cases with dolichosegmental intracranial arteries as a new feature of PHACES syndrome.

Authors:  Carlos E Baccin; Timo Krings; Hortensia Alvarez; Augustin Ozanne; Pierre L Lasjaunias
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

3.  Arterial anomalies at the base of the skull.

Authors:  P Lasjaunias; J Moret; C Manelfe; J Théron; T Hasso; J Seeger
Journal:  Neuroradiology       Date:  1977-07-29       Impact factor: 2.804

4.  Intracranial infantile hemangiomas associated with PHACE syndrome.

Authors:  C D Judd; P R Chapman; B Koch; C J Shea
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

5.  A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications.

Authors:  D W Metry; A N Haggstrom; B A Drolet; E Baselga; S Chamlin; M Garzon; K Horii; A Lucky; A J Mancini; B Newell; A Nopper; G Heyer; I J Frieden
Journal:  Am J Med Genet A       Date:  2006-05-01       Impact factor: 2.802

6.  Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma.

Authors:  Mark E Kleinman; Matthew R Greives; Samara S Churgin; Keith M Blechman; Eric I Chang; Daniel J Ceradini; Oren M Tepper; Geoffrey C Gurtner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-13       Impact factor: 8.311

7.  Parabiotic twin syndrome with topical isocortical disruption and gastroschisis.

Authors:  P G Barth; J J van der Harten
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Consensus Statement on Diagnostic Criteria for PHACE Syndrome.

Authors:  Denise Metry; Geoffrey Heyer; Christopher Hess; Maria Garzon; Anita Haggstrom; Peter Frommelt; Denise Adams; Dawn Siegel; Karla Hall; Julie Powell; Ilona Frieden; Beth Drolet
Journal:  Pediatrics       Date:  2009-10-26       Impact factor: 7.124

9.  Facial hemangioma and hemispheric migration disorder: presentation of 5 patients.

Authors:  I Pascual-Castroviejo; S-I Pascual-Pascual; J-C López-Gutiérrez; R Velazquez-Fragua; J Viaño
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

10.  The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain.

Authors:  H C Etchevers; C Vincent; N M Le Douarin; G F Couly
Journal:  Development       Date:  2001-04       Impact factor: 6.868

View more
  27 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Enlargement of the Internal Auditory Canal and Associated Posterior Fossa Anomalies in PHACES Association.

Authors:  D E Meltzer; C D Robson; F Blei; R A Holliday
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-09       Impact factor: 3.825

3.  Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.

Authors:  Jeffrie Hadisurya; Stephanie Guey; Lou Grangeon; Dagmar Wieczorek; Michaelle Corpechot; Jan Claudius Schwitalla; Markus Kraemer
Journal:  Childs Nerv Syst       Date:  2019-04-29       Impact factor: 1.475

4.  PHACE syndrome and cerebral cavernous malformations: association or simply microhemorrhages?

Authors:  Mark D Mamlouk; Mohit Maheshwari; Patricia E Burrows; Dawn H Siegel; Ilona J Frieden; Beth A Drolet; Christopher P Hess
Journal:  Childs Nerv Syst       Date:  2017-06-16       Impact factor: 1.475

5.  PHACE syndrome: MRI of intracerebral vascular anomalies and clinical findings in a series of 12 patients.

Authors:  Jennifer Bracken; Ian Robinson; Aisling Snow; Rosemarie Watson; Alan D Irvine; David Rea; Ethna Phelan
Journal:  Pediatr Radiol       Date:  2011-06-15

6.  Structural malformations of the brain, eye, and pituitary gland in PHACE syndrome.

Authors:  Jack E Steiner; Garrett N McCoy; Christopher P Hess; William B Dobyns; Denise W Metry; Beth A Drolet; Mohit Maheshwari; Dawn H Siegel
Journal:  Am J Med Genet A       Date:  2017-11-24       Impact factor: 2.802

7.  Dolichoectasia of the internal carotid artery terminus, posterior communicating artery, and posterior cerebral artery: The embryonic caudal ramus internal carotid segmental vulnerability legacy.

Authors:  Chai Kobkitsuksakul; Kittiphop Somboonnitiphol; Mungkorn Apirakkan; Peerapong Luengapapong; Ekachat Chanthanaphak
Journal:  Interv Neuroradiol       Date:  2020-06-05       Impact factor: 1.610

8.  Concomitant carotid aplasia and basilar artery occlusion in a child with PHACES syndrome.

Authors:  Noel Delgado; Jason J Carroll; Philip M Meyers
Journal:  BMJ Case Rep       Date:  2017-08-16

9.  Cardio-cephalic neural crest syndrome: A novel hypothesis of vascular neurocristopathy.

Authors:  M Komiyama
Journal:  Interv Neuroradiol       Date:  2017-08-16       Impact factor: 1.610

10.  PHACE syndrome is associated with intracranial cavernous malformations.

Authors:  Kimberly A Foster; William J Ares; Zachary J Tempel; Andrew A McCormick; Ashok Panigrahy; Lorelei J Grunwaldt; Stephanie Greene
Journal:  Childs Nerv Syst       Date:  2016-04-28       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.